Found: 122
Select item for more details and to access through your institution.
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registry.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 7, p. 1318, doi. 10.1111/jgh.16556
- By:
- Publication type:
- Article
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650
- By:
- Publication type:
- Article
A hierarchical fusion strategy of deep learning networks for detection and segmentation of hepatocellular carcinoma from computed tomography images.
- Published in:
- Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00686-8
- By:
- Publication type:
- Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 375, doi. 10.1007/s10120-023-01455-5
- By:
- Publication type:
- Article
Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11889-4
- By:
- Publication type:
- Article
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 287, doi. 10.3390/ijms25010287
- By:
- Publication type:
- Article
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 29, doi. 10.1159/000530950
- By:
- Publication type:
- Article
Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic Disability.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 267, doi. 10.1016/j.clcc.2023.03.003
- By:
- Publication type:
- Article
The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 16, p. 16906, doi. 10.1002/cam4.6320
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
- By:
- Publication type:
- Article
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
- By:
- Publication type:
- Article
A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 years.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1090, doi. 10.1002/cam4.4960
- By:
- Publication type:
- Article
The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1540, doi. 10.1002/cam4.5045
- By:
- Publication type:
- Article
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2355, doi. 10.3390/v14112355
- By:
- Publication type:
- Article
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11335, doi. 10.3390/ijms231911335
- By:
- Publication type:
- Article
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 5, p. 943, doi. 10.1007/s10120-022-01308-7
- By:
- Publication type:
- Article
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 789, doi. 10.1007/s10637-022-01248-0
- By:
- Publication type:
- Article
Outcomes of patients with malignant duodenal obstruction after receiving self-expandable metallic stents: A single center experience.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0268920
- By:
- Publication type:
- Article
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221099401
- By:
- Publication type:
- Article
Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12350-x
- By:
- Publication type:
- Article
Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 2014, doi. 10.3390/cancers14082014
- By:
- Publication type:
- Article
Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 7, p. 1955, doi. 10.1111/jcmm.17220
- By:
- Publication type:
- Article
Bifocal lesions have a poorer treatment outcome than a single lesion in adult patients with intracranial germinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264641
- By:
- Publication type:
- Article
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 218, doi. 10.3390/cancers14010218
- By:
- Publication type:
- Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 207, doi. 10.1007/s10120-021-01230-4
- By:
- Publication type:
- Article
Survival outcomes of management in metastatic gastric adenocarcinoma patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02391-z
- By:
- Publication type:
- Article
Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 572, doi. 10.1159/000518728
- By:
- Publication type:
- Article
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 629, doi. 10.1159/000517393
- By:
- Publication type:
- Article
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4325, doi. 10.3390/cancers13174325
- By:
- Publication type:
- Article
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94968-x
- By:
- Publication type:
- Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 946, doi. 10.1007/s10120-021-01173-w
- By:
- Publication type:
- Article
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6940, doi. 10.3390/ijms22136940
- By:
- Publication type:
- Article
Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.632609
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.620361
- By:
- Publication type:
- Article
Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 865, doi. 10.1002/cncr.33317
- By:
- Publication type:
- Article
Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75198-z
- By:
- Publication type:
- Article
A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1280, doi. 10.1634/theoncologist.2020-0143
- By:
- Publication type:
- Article
The Clinicopathological Characteristics And Genetic Alterations of Signet-ring Cell Carcinoma in Gastric Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2318, doi. 10.3390/cancers12082318
- By:
- Publication type:
- Article
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1145
- By:
- Publication type:
- Article
The Clinicopathological Features and Genetic Alterations in Epstein–Barr Virus-Associated Gastric Cancer Patients after Curative Surgery.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1517, doi. 10.3390/cancers12061517
- By:
- Publication type:
- Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 3, p. 510, doi. 10.1007/s10120-019-01034-7
- By:
- Publication type:
- Article
An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490
- By:
- Publication type:
- Article
The Clinicopathological Features and Genetic Mutations in Gastric Cancer Patients According to EMAST and MSI Status.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 551, doi. 10.3390/cancers12030551
- By:
- Publication type:
- Article
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 182, doi. 10.3390/cancers12010182
- By:
- Publication type:
- Article
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 143, doi. 10.1007/s10120-019-00970-8
- By:
- Publication type:
- Article
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1534, doi. 10.1634/theoncologist.2019-0171
- By:
- Publication type:
- Article
Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0747-5
- By:
- Publication type:
- Article